The Eye Patch and Headset on Sleep Quality, Anxiety, Fear and Vital Signs
The Effect of Eye Patch and Headset on Sleep Quality, Anxiety, Fear and Vital Signs in Intensive Care Patients: A Randomized Controlled Study
1 other identifier
interventional
60
1 country
1
Brief Summary
This study was planned to investigate the effects of eye patch and headphones on sleep quality, anxiety, fear and vital signs in coronary intensive care unit patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jun 2022
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 20, 2022
CompletedFirst Submitted
Initial submission to the registry
July 6, 2022
CompletedFirst Posted
Study publicly available on registry
July 11, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 15, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
November 15, 2022
CompletedFebruary 13, 2023
February 1, 2023
5 months
July 6, 2022
February 10, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Visual Analog Scale (Fear)
Patients are asked to show the severity of their fear on a 10 cm long vertical or horizontal line. In addition, there were forms which were numbered from 1-10 or from 1-100. The number 0 is found at the beginning of the line, and the number 10 is located at the end of the line. A value of 0 shows that there is no pain, and the value 10 expresses unendurable pain. GAS is a common scale in the assessment of pain level. A patient is asked to mark the perceived pain on this line, and the marked point is measured in cm.
the first day after receiving randomisation
Visual Analog Scale (Anxiety)
Patients are asked to show the severity of their anxiety on a 10 cm long vertical or horizontal line. In addition, there were forms which were numbered from 1-10 or from 1-100. The number 0 is found at the beginning of the line, and the number 10 is located at the end of the line. A value of 0 shows that there is no pain, and the value 10 expresses unendurable pain. GAS is a common scale in the assessment of pain level. A patient is asked to mark the perceived pain on this line, and the marked point is measured in cm.
the first day after receiving randomisation
Vital Signs Follow-up Form
This form was created by the researcher in order to record the systolic-diastolic blood pressure, and heart rate (pulse), values of the patient who was applied an eye patch or earphone at night.
the first day after receiving randomisation
The Richards-Campbell Sleep Questionnaire
This brief five-item questionnaire was used to evaluate perceived sleep depth, sleep latency (time to fall asleep), number of awakenings, efficiency (percentage of time awake), and sleep quality. It also includes a sixth item evaluating perceived night-time noise. Each item is evaluated on a scale of 0-100 with a visual analogue scale technique. A score of 0-25 indicates very poor quality sleep, whereas a score of 76-100 indicates very good sleep quality.
the first day after receiving randomisation
Secondary Outcomes (4)
Visual Analog Scale (Fear)
4. days
Visual Analog Scale (Anxiety)
4. days
Vital Signs Follow-up Form
4. days
The Richards-Campbell Sleep Questionnaire
4. days
Study Arms (2)
Eye patch and headphones
EXPERIMENTALEye patch and headphones
Control group
NO INTERVENTIONRoutine maintenance will be applied
Interventions
Patients in the experimental group will be asked to use an eye mask and earplugs from 22:30 to 6:30 in the morning on the 1st, 2nd and 3rd nights.
Eligibility Criteria
You may qualify if:
- Being 18 years or older,
- New York Heart Association (NYHA) functional class II and III,
- Not having received any general anaesthesia for the previous 24 hours,
- Not having received any sedative medications or opioids for the past 24 hours,
- Not having a verbal communication disability (hearing and speaking),
- Absence of pain,
- Not having a previously diagnosed sleep disorder,
- Not having psychiatric problems,
- Not having a cognitive problem,
- Being healthy enough to put on and take off earplugs independently, in addition to wearing an eye mask and removing it when necessary, and continuing to be hospitalized for at least three days.
You may not qualify if:
- Diagnosed with delirium (Intensive care delirium screening checklist \>=5),
- Unconscious (Glasgow coma scale\<13),
- Presence of additional chronic diseases,
- Having consumed coffee, alcohol and hypnotic drugs at least 12 hours before the study,
- Patients whose condition suddenly worsened,
- Those who cannot use earplugs and eye masks effectively at night,
- Those who voluntarily withdrew from the study and were transferred from the intensive care unit.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Istanbul Sabahattin Zaim University, Faculty of Health Sciences
Istanbul, 34340, Turkey (Türkiye)
Related Publications (1)
Kasapoglu ES, Enc N. Role of multicomponent non-pharmacological nursing interventions on delirium prevention: A randomized controlled study. Geriatr Nurs. 2022 Mar-Apr;44:207-214. doi: 10.1016/j.gerinurse.2022.02.015. Epub 2022 Feb 26.
PMID: 35227973RESULT
Study Officials
- STUDY DIRECTOR
Zülfünaz Özer
Istanbul Sabahattin Zaim University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- Experimental group and control group
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Investigator
Study Record Dates
First Submitted
July 6, 2022
First Posted
July 11, 2022
Study Start
June 20, 2022
Primary Completion
November 15, 2022
Study Completion
November 15, 2022
Last Updated
February 13, 2023
Record last verified: 2023-02
Data Sharing
- IPD Sharing
- Will not share